Biotechin.AsiaSynthetic biology, slippery slopes and the bandwagon theoryBiotechin.AsiaI admit, I regret not attending the International Meeting on Synthetic Biology that took place recently. When I sat down to watch the live stream from the comfort of… Continue reading
|
So Long To KITE; JUNO, CLLS, MBIO, BLCM Are Sympathy Plays; PGNX Catches Eye
Nasdaq Kite Pharma is a clinical-stage developer of chimeric antigen receptor (CAR) T-cell therapies. CAR T-cells are a type of immunotherapy in which a patient’s T cells are extracted from their blood and modified in a lab to produce receptors on their … |
Los Angeles Times |
FDA cracks down on clinics selling unproven stem cell ‘therapies’
Los Angeles Times The Food and Drug Administration has launched an opening salvo at a booming national market for suspect medical treatments, announcing actions that could rein in clinics offering questionable stem–cell treatments for cancer and other diseases. The FDA … FDA Cracks Down on ‘Unscrupulous’ Stem Cell ClinicsNew York Times FDA Cracks Down On Stem–Cell Clinics Selling Unapproved TreatmentsNPR FDA cracks down on stem cell clinicsCNN Ars Technica –Washington Post –Minneapolis Star Tribune –FDA.gov all 44 news articles » |
FierceBiotech |
Boosting immunotherapy by targeting cells’ recycling centers
FierceBiotech A subpopulation of cells in the immune system called CD8+ T cells are vital for the proper functioning of both vaccines and cancer immunotherapy treatments. When these cells divide, they become one of two types of pathogen-destroying soldiers: those … Boosting immune cell memory to improve vaccines and cancer immunotherapyEurekAlert (press release) |
Medical Xpress |
Bone marrow protein may be target for improving stem cell transplants
Medical Xpress Del-1, a protein previous shown to play a role in gum disease, has now been found to help regulate the production of blood cells. Targeting it could be an effective way to improve stem cell transplants for both donors and recipients. There …more. |
The News Tribune (blog) |
Why Doug Baldwin went to England for stem–cell therapy
The News Tribune (blog) RENTON Turns out, Doug Baldwin started this current Seahawks fad of traveling outside the team’s normal medical coverage to get far-flung treatment using body cells. The Seahawks’ No. 1 wide receiver told me Monday he went overseas before this season … |